Clinical Trials
5
Active:0
Completed:5
Trial Phases
2 Phases
Phase 1:2
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (50.0%)Phase 2
2 (50.0%)Safety Study of SLC-0111 in Subjects With Advanced Solid Tumours
- First Posted Date
- 2014-08-13
- Last Posted Date
- 2016-05-17
- Lead Sponsor
- Welichem Biotech Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT02215850
- Locations
- 🇨🇦
Alberta Health Services - Cross Cancer Institute, Edmonton, Alberta, Canada
🇨🇦British Columbia Cancer Agency, Vancouver, British Columbia, Canada
🇨🇦Princess Margaret Cancer Centre, Toronto, Ontario, Canada
A Safety/Efficacy Study of a Non-steroid, Topical Cream Treatment of Psoriasis Over 12-weeks
- First Posted Date
- 2010-04-05
- Last Posted Date
- 2012-12-20
- Lead Sponsor
- Welichem Biotech Inc.
- Target Recruit Count
- 61
- Registration Number
- NCT01098721
Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream
- First Posted Date
- 2010-04-05
- Last Posted Date
- 2011-06-13
- Lead Sponsor
- Welichem Biotech Inc.
- Target Recruit Count
- 148
- Registration Number
- NCT01098734
- Locations
- 🇨🇦
Guilford Dermatology Associates, Surrey, British Columbia, Canada
🇨🇦Department of Dermatology and Skin Sciences, UBC, Vancouver, British Columbia, Canada
🇨🇦Windsor Clinical Research Inc., Windsor, Ontario, Canada
Phase IIa Study of WBI-1001 Cream for Atopic Dermatitis
- First Posted Date
- 2009-02-05
- Last Posted Date
- 2009-02-05
- Lead Sponsor
- Welichem Biotech Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT00837551
- Locations
- 🇨🇦
Innovaderm Research Inc.,, Montreal, Quebec, Canada
Double-Blind Study of Topical WBI-1001 Cream on Patients With Psoriasis
Completed
- Conditions
- Psoriasis
- First Posted Date
- 2009-01-28
- Last Posted Date
- 2009-01-28
- Lead Sponsor
- Welichem Biotech Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT00830817
- Locations
- 🇨🇦
Innovaderm Research inc., Montreal, Quebec, Canada
News
No news found